Genmab broadens ADC pipeline with $1.8bn acquisition of ProfoundBio
Genmab announced today that it will acquire privately held biotech company ProfoundBio for $1.8bn in cash. The deal is designed to help the Danish pharmaceutical company deepen its cancer pipeline […]